Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Serum Citrin and γ-Glutamyl Transferase as Biomarkers for Infantile Cholestasis Severity


Affiliations
1 Lecturer Ph. D. Department of Pharmacy, Al-Israa University, Baghdad, Iraq
2 Assist Prof. Dr. Department of Chemistry and Biochemistry, College of Medicine, Al-Nahrain University, Baghdad, Iraq
3 Assist Prof. Dr. Department of Pediatric, College of Medicine, Al-Nahrain University, Baghdad, Iraq
     

   Subscribe/Renew Journal


One of the most important parameters to evaluate severity and type of cholestasis disease is gamma-glutamyl transferase and citrin protein measurements. The objective of this study was to assess the clinical value of serum citrin protein with gamma-glutamyl transferase in children with cholestasis. 60 subjects with diseases and 25 healthy subjects distributed intothree groups, citrinand gamma-glutamyl transferasewere measured for all case and control studies by enzyme linked immunosorbent Assay. The results showed serum citrin has a highly significantly decreased in an intra- and extrahepatic cholestasis groups when compared with control (P<0.001), serum gamma-glutamyl transferasehas a highly significantly elevated in an intrahepatic cholestasis group when compared with control (P<0.003). From these findings it was concluded that serum gamma-glutamyl transferase level is a good marker in determining the severity of cholestasis disease, serum citrin may be useful in future to diagnose the cholestasis caused by citrin deficiency.

Keywords

γ-Glutamyl transferase (GGT), Biliary atresia (BA), Alagille syndrome (AGS), Progressive familial intrahepatic cholestasis (PFIC), Idiopathic neonatal hepatitis (INH), Citrin deficiency (CD).
Subscription Login to verify subscription
User
Notifications
Font Size


Abstract Views: 385

PDF Views: 0




  • Serum Citrin and γ-Glutamyl Transferase as Biomarkers for Infantile Cholestasis Severity

Abstract Views: 385  |  PDF Views: 0

Authors

Mostafa Al-Bassam
Lecturer Ph. D. Department of Pharmacy, Al-Israa University, Baghdad, Iraq
Hassan H. AL-Saeed
Assist Prof. Dr. Department of Chemistry and Biochemistry, College of Medicine, Al-Nahrain University, Baghdad, Iraq

Assist Prof. Dr. Department of Pediatric, College of Medicine, Al-Nahrain University, Baghdad, Iraq

Abstract


One of the most important parameters to evaluate severity and type of cholestasis disease is gamma-glutamyl transferase and citrin protein measurements. The objective of this study was to assess the clinical value of serum citrin protein with gamma-glutamyl transferase in children with cholestasis. 60 subjects with diseases and 25 healthy subjects distributed intothree groups, citrinand gamma-glutamyl transferasewere measured for all case and control studies by enzyme linked immunosorbent Assay. The results showed serum citrin has a highly significantly decreased in an intra- and extrahepatic cholestasis groups when compared with control (P<0.001), serum gamma-glutamyl transferasehas a highly significantly elevated in an intrahepatic cholestasis group when compared with control (P<0.003). From these findings it was concluded that serum gamma-glutamyl transferase level is a good marker in determining the severity of cholestasis disease, serum citrin may be useful in future to diagnose the cholestasis caused by citrin deficiency.

Keywords


γ-Glutamyl transferase (GGT), Biliary atresia (BA), Alagille syndrome (AGS), Progressive familial intrahepatic cholestasis (PFIC), Idiopathic neonatal hepatitis (INH), Citrin deficiency (CD).



DOI: https://doi.org/10.37506/v11%2Fi2%2F2020%2Fijphrd%2F195200